Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, announced today it has entered a strategic partnership with YUN NV, an innovative leader in microbiome skincare solutions. This collaboration is set to transform the skincare landscape, starting with the launch of YUN’s probiotic-based products for acne-prone skin to the Polish market later this year.
YUN, known for its pioneering probiotherapeutical skincare products, and Bausch Health, a leader in the market, are combining their strengths to bring microbiome skincare solutions to new patients. The first phase of the partnership will introduce YUN’s probiotic-based acne-prone skincare range to Poland later this year. These microbiome skincare solutions use live probiotics to help restore the skin’s natural microbiome balance, offering a modern, science-driven approach to managing acne-prone skin. This partnership marks a significant step in expanding Bausch Health’s portfolio into the emerging space of probiotherapy, a microbiome skincare approach.
“At Bausch Health, we constantly seek innovative solutions that enrich people’s lives. Partnering with YUN is an exciting step forward in delivering cutting-edge microbiome technologies for acne-prone skincare in Poland, with plans to expand into other countries,”
said Cees Heiman, Senior Vice President, Europe and Canada, Bausch Health
“We’re honored to partner with Bausch Health, whose strong market presence and commitment to patient well-being align with our mission to empower people and restore balance by supporting the microbiome and offering natural, effective solutions that go beyond symptoms,”
said Tom Verlinden, Chief Executive Officer and Founder, YUN NV.
“This partnership validates our scientific and therapeutic vision, sharing a joint ambition to unlock the full potential of microbiome in skincare.”
Both companies share a commitment to enhancing health through innovative, science-backed solutions. By joining forces, they aim to improve skin health through the science of the microbiome.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.
About Yun NV
YUN is a Belgian biotech company redefining everyday care through microbiome science. Founded in 2016, YUN developed the patented YUN Probiotherapy™ platform, featuring live probiotics and microbiome-friendly formulations designed to respect and support the skin’s natural balance. With innovations across dermatological, oral, baby, intimate, and ear care, YUN delivers science- and quality-driven, nature-powered solutions for health-conscious patients and consumers, today and for generations to come. For more information about YUN, visit www.yun-probiotherapy.com and connect with us on LinkedIn.